RxDoctor Payments DataLook up a doctor →

Saakshi Khattri, MD

Dermatology · New York, NYNPI 1265677033

Payments from drug & device makers

$15,363,498in general payments, 2019–2025

Across 2,875 payments — averaging $5343.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$9.5M
  • Pfizer$1.9M
  • AbbVie$712K
  • Incyte Corporation$419K
  • Amgen$323K
  • Lilly USA, LLC$315K
  • plus $2.2M from 38 others
$26,087in research payments, 2019–2025

Across 4 payments — averaging $6521.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$21K
  • Ichnos Glenmark Innovation Inc$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,363,498 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York

Medicare billing

Part B allowed, 2024
$150,091
Medicare patients
385
Services billed
1,332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →